FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894569178> ?p ?o ?g. }

• W2894569178 endingPage "501" @default.
• W2894569178 startingPage "492" @default.
• W2894569178 abstract "The optimal anti-coagulation strategy for patients with non-ST-elevation myocardial infarction treated with percutaneous coronary intervention is unclear in contemporary clinical practice of radial access and potent P2Y12-inhibitors. The aim of this study was to investigate whether bivalirudin was superior to heparin monotherapy in patients with non-ST-elevation myocardial infarction without routine glycoprotein IIb/IIIa inhibitor use.In a large pre-specified subgroup of the multicentre, prospective, randomised, registry-based, open-label clinical VALIDATE-SWEDEHEART trial we randomised patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention, treated with ticagrelor or prasugrel, to bivalirudin or heparin monotherapy with no planned use of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention. The primary endpoint was the rate of a composite of all-cause death, myocardial infarction or major bleeding within 180 days.A total of 3001 patients with non-ST-elevation myocardial infarction, were enrolled. The primary endpoint occurred in 12.1% (182 of 1503) and 12.5% (187 of 1498) of patients in the bivalirudin and heparin groups, respectively (hazard ratio of bivalirudin compared to heparin treatment 0.96, 95% confidence interval 0.78-1.18, p=0.69). The results were consistent in all major subgroups. All-cause death occurred in 2.0% versus 1.7% (hazard ratio 1.15, 0.68-1.94, p=0.61), myocardial infarction in 2.3% versus 2.5% (hazard ratio 0.91, 0.58-1.45, p=0.70), major bleeding in 8.9% versus 9.1% (hazard ratio 0.97, 0.77-1.24, p=0.82) and definite stent thrombosis in 0.3% versus 0.2% (hazard ratio 1.33, 0.30-5.93, p=0.82).Bivalirudin as compared to heparin during percutaneous coronary intervention for non-ST-elevation myocardial infarction did not reduce the composite of all-cause death, myocardial infarction or major bleeding in non-ST-elevation myocardial infarction patients receiving current recommended treatments with modern P2Y12-inhibitors and predominantly radial access." @default.
• W2894569178 created "2018-10-12" @default.
• W2894569178 creator A5000214308 @default.
• W2894569178 creator A5003216491 @default.
• W2894569178 creator A5015768545 @default.
• W2894569178 creator A5019796253 @default.
• W2894569178 creator A5024753923 @default.
• W2894569178 creator A5029608556 @default.
• W2894569178 creator A5030483444 @default.
• W2894569178 creator A5038519757 @default.
• W2894569178 creator A5040799356 @default.
• W2894569178 creator A5045986754 @default.
• W2894569178 creator A5046573002 @default.
• W2894569178 creator A5051178773 @default.
• W2894569178 creator A5058381204 @default.
• W2894569178 creator A5063591215 @default.
• W2894569178 creator A5066461789 @default.
• W2894569178 creator A5068969400 @default.
• W2894569178 creator A5073596004 @default.
• W2894569178 creator A5077055608 @default.
• W2894569178 creator A5077357021 @default.
• W2894569178 creator A5077479383 @default.
• W2894569178 creator A5079991822 @default.
• W2894569178 creator A5085932991 @default.
• W2894569178 creator A5088680226 @default.
• W2894569178 date "2018-10-03" @default.
• W2894569178 modified "2023-10-18" @default.
• W2894569178 title "Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction" @default.
• W2894569178 cites W1278248171 @default.
• W2894569178 cites W2030271409 @default.
• W2894569178 cites W2056697517 @default.
• W2894569178 cites W2073159589 @default.
• W2894569178 cites W2099409915 @default.
• W2894569178 cites W2102296549 @default.
• W2894569178 cites W2114758846 @default.
• W2894569178 cites W2121251309 @default.
• W2894569178 cites W2121908294 @default.
• W2894569178 cites W2125043491 @default.
• W2894569178 cites W2127407584 @default.
• W2894569178 cites W2138452995 @default.
• W2894569178 cites W2140501627 @default.
• W2894569178 cites W2150655309 @default.
• W2894569178 cites W2156927593 @default.
• W2894569178 cites W2169387542 @default.
• W2894569178 cites W2281127076 @default.
• W2894569178 cites W2333133657 @default.
• W2894569178 cites W2333929093 @default.
• W2894569178 cites W2523777014 @default.
• W2894569178 cites W2621797011 @default.
• W2894569178 cites W2624188282 @default.
• W2894569178 cites W2745712984 @default.
• W2894569178 cites W4236531408 @default.
• W2894569178 cites W56633917 @default.
• W2894569178 doi "https://doi.org/10.1177/2048872618805663" @default.
• W2894569178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30281320" @default.
• W2894569178 hasPublicationYear "2018" @default.
• W2894569178 type Work @default.
• W2894569178 sameAs 2894569178 @default.
• W2894569178 citedByCount "6" @default.
• W2894569178 countsByYear W28945691782019 @default.
• W2894569178 countsByYear W28945691782020 @default.
• W2894569178 countsByYear W28945691782021 @default.
• W2894569178 countsByYear W28945691782023 @default.
• W2894569178 crossrefType "journal-article" @default.
• W2894569178 hasAuthorship W2894569178A5000214308 @default.
• W2894569178 hasAuthorship W2894569178A5003216491 @default.
• W2894569178 hasAuthorship W2894569178A5015768545 @default.
• W2894569178 hasAuthorship W2894569178A5019796253 @default.
• W2894569178 hasAuthorship W2894569178A5024753923 @default.
• W2894569178 hasAuthorship W2894569178A5029608556 @default.
• W2894569178 hasAuthorship W2894569178A5030483444 @default.
• W2894569178 hasAuthorship W2894569178A5038519757 @default.
• W2894569178 hasAuthorship W2894569178A5040799356 @default.
• W2894569178 hasAuthorship W2894569178A5045986754 @default.
• W2894569178 hasAuthorship W2894569178A5046573002 @default.
• W2894569178 hasAuthorship W2894569178A5051178773 @default.
• W2894569178 hasAuthorship W2894569178A5058381204 @default.
• W2894569178 hasAuthorship W2894569178A5063591215 @default.
• W2894569178 hasAuthorship W2894569178A5066461789 @default.
• W2894569178 hasAuthorship W2894569178A5068969400 @default.
• W2894569178 hasAuthorship W2894569178A5073596004 @default.
• W2894569178 hasAuthorship W2894569178A5077055608 @default.
• W2894569178 hasAuthorship W2894569178A5077357021 @default.
• W2894569178 hasAuthorship W2894569178A5077479383 @default.
• W2894569178 hasAuthorship W2894569178A5079991822 @default.
• W2894569178 hasAuthorship W2894569178A5085932991 @default.
• W2894569178 hasAuthorship W2894569178A5088680226 @default.
• W2894569178 hasBestOaLocation W28945691781 @default.
• W2894569178 hasConcept C126322002 @default.
• W2894569178 hasConcept C164705383 @default.
• W2894569178 hasConcept C203092338 @default.
• W2894569178 hasConcept C207103383 @default.
• W2894569178 hasConcept C2776884760 @default.
• W2894569178 hasConcept C2777557582 @default.
• W2894569178 hasConcept C2777565915 @default.
• W2894569178 hasConcept C2778825682 @default.
• W2894569178 hasConcept C2780400711 @default.
• W2894569178 hasConcept C44249647 @default.

• next